Table 1.
Treatment | Males | Females |
---|---|---|
M0P0 | 30.43 ± 0.32 | 29.73 ± 5.84 |
M0P1 | 28.01 ± 2.63 | 34.49 ± 3.07 |
M0P3 | 31.10 ± 1.34 | 30.51 ± 3.39 |
M3P0 | 29.16 ± 1.00 | 37.93 ± 6.83 |
M3P1 | 27.39 ± 0.82 | 35.17 ± 2.16 |
M3P3 | 33.47 ± 2.58 | 35.91 ± 0.49 |
M6P0 | 34.99 ± 3.76 | 31.62 ± 1.90 |
M6P1 | 33.14 ± 4.45 | 29.77 ± 3.84 |
M6P3 | 28.84 ± 2.41 | 32.64 ± 2.43 |
Values are optical density × mm2 levels ± SE as determined by electrophoresis gel densitometry. ANOVA did not reveal any significant difference among CPF treatment groups.